Sirolimus has anti-skin cancer effect in kidney transplant patients
13:15 EDT 27 Jul 2012 | The Medical News
Switching from calcineurin inhibitors to a sirolimus-containing immunosuppression regimen may help reduce the incidence of secondary skin cancer after kidney transplantation, suggests research published in TheNew England Journal of Medicine.
Original Article: Sirolimus has anti-skin cancer effect in kidney transplant patients
More From BioPortfolio on "Sirolimus has anti-skin cancer effect in kidney transplant patients"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
